戻る Agenda
European Medicines Regulatory Network Strategy to 2025
Session Chair(s)
Melanie Carr
Head of Stakeholders and Communication Division
European Medicines Agency, Netherlands
This DIAmond session will illustrate the European Medicines Agencies Network Strategy 2025 and debate how this strategy aims at addressing challenges and creating opportunities for health care systems. Hear from the EMA and HMA on the creation, consultation and planned implementation of the European Medicines Agencies Network Strategy 2025 and gain insights on the perspective of stakeholders including patient representatives, healthcare professionals and industry.
Speaker(s)
How did we arrive at the strategy?
Melanie Carr
European Medicines Agency, Netherlands
Head of Stakeholders and Communication Division
Pharmaceutical Industry’s Reflection on What Should be Addressed in Coming 5 Years
Nathalie Moll
European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Director General
Panelist
Adrian van den Hoven
Medicines for Europe, Belgium
Director General
Future Priorities from a Health Care Professional’s Perspective
Ulrich Jaeger, DrMed
Medizinische Universität Wien, Austria
Professor
Patient’s Viewpoint on Key Areas Where Change or Further Action is Needed
Marco Greco, PhD
European Patients' Forum, Belgium
President
Implementation of the Strategy
Thomas Heberer
Federal Office of Consumer Protection and Food Safety, Germany
Head of Dept. 3 „Veterinary Medicinal Products“